SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-011295
Filing Date
2022-07-28
Accepted
2022-07-28 17:07:22
Documents
12
Period of Report
2022-07-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20220725x8k.htm   iXBRL 8-K 39009
  Complete submission text file 0001558370-22-011295.txt   161873

Data Files

Seq Description Document Type Size
2 EX-101.SCH xlo-20220725.xsd EX-101.SCH 3031
3 EX-101.LAB xlo-20220725_lab.xml EX-101.LAB 16584
4 EX-101.PRE xlo-20220725_pre.xml EX-101.PRE 10714
6 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20220725x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 221116133
SIC: 2834 Pharmaceutical Preparations